SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-12-025944
Filing Date
2012-04-17
Accepted
2012-04-17 16:38:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-9900_1sc13da.htm SC 13D/A 172766
2 EX-2 a12-9900_1ex2.htm EX-2 162437
3 EX-11 a12-9900_1ex11.htm EX-11 147535
  Complete submission text file 0001104659-12-025944.txt   484253
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 12764084
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA PALERMO 26/A PARMA L6 43122
Business Address VIA PALERMO 26/A PARMA L6 43122 39.0521.279.1
Chiesi Farmaceutici SpA (Filed by) CIK: 0001464415 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A